David S. Tierney - Dec 12, 2023 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ David S. Tierney
Stock symbol
CPRX
Transactions as of
Dec 12, 2023
Transactions value $
-$609,750
Form type
4
Date filed
12/14/2023, 05:00 PM
Previous filing
Dec 12, 2023
Next filing
Dec 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $56.5K +50K +14.99% $1.13* 384K Dec 12, 2023 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$666K -50K -13.04% $13.33 334K Dec 12, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 +50K +25.74% $0.00 244K Dec 12, 2023 Common Stock 50K $1.13 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market for personal reasons, and to fund the exercise price for stock options expiring on January 3, 2024, and not as a result of any disagreement with the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $13.30 to $13.36 per share.
F3 Options vested in three annual tranches beginning on January 3, 2018.